Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $16.2200 (-2.29%) ($16.2200 - $16.2200) on Thu. Mar. 10, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.48% (three month average) | RSI | 56 | Latest Price | $16.2200(-2.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.5% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(69%) IWO(63%) IBUY(62%) IWC(62%) IWM(60%) | Factors Impacting EDIT price | EDIT will decline at least -2.24% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-11%) TBT(-10%) EDOC(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.24% (StdDev 4.48%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $16.25 | 5 Day Moving Average | $16.18(0.25%) | 10 Day Moving Average | $16.6(-2.29%) | 20 Day Moving Average | $16.25(-0.18%) | To recent high | -46.4% | To recent low | 12.6% | Market Cap | $1.007b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |